FDA Inspection 1259306 — Guangzhou Hanpu Pharmaceutical Co. Ltd.
The FDA completed an inspection of Guangzhou Hanpu Pharmaceutical Co. Ltd. on Dec 13, 2024 in Guangzhou. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Veterinary.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Dec 13, 2024
- Fiscal Year
- 2025
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Guangzhou (China)